-
In the extended HIV prevention plan by the Centers for Disease Control and Prevention (CDC) in Atlanta, GA, there is renewed focus on expanding HIV testing and focusing on African Americans and the men who have sex with men (MSM) communities.
-
The national five-year HIV strategic prevention plan, launched in 2001, was a failure. Everyone agrees with this assessment, including the agency that created it: the Centers for Disease Control and Prevention (CDC) of Atlanta, GA.
-
On Dec. 20, 2007, the FDA granted tentative approval for a generic formulation of efavirenz tablets, 600 mg, manufactured by Emcure Pharmaceuticals of Pune, India The application was reviewed under the expedited review provisions of the President's Emergency Plan for AIDS Relief (PEPFAR).
-
HIV vaccine trials likely will continue for a decade or longer, raising questions about ethical considerations of enrolling participants across the globe.
-
Short-term Milestone 1: By 2010, decrease by at least 10 percent the number of persons in the United States at high risk for acquiring or transmitting HIV infection by delivering targeted, sustained and evidence-based HIV prevention interventions.
-
-
The National Center for Complementary and Alternative Medicine (NCCAM) in Bethesda, MD, has announced a research career development award for CAM practitioners.
-
There is much room for improvement for the vast majority of The Joint Commission's standardized national performance measures, according to data reported in Improving America's Hospitals: The Joint Commission's Annual Report on Quality and Safety 2007. A 90% compliance level was achieved for only four of 22 quality-related measures tracked during 2006.
-
Since the implementation of National Patient Safety Goals (NPSGs) dealing with medication reconciliation in 2005, The Joint Commission has received a steady stream of feedback from the medical community. Emergency medicine experts and organizations, in particular, have complained that the goals were unclear and made compliance difficult.
-
The Joint Commission has added an initial set of seven hospital outpatient measures to its current complement of core measure sets that may be used to satisfy ORYX performance measurement requirements.
